Join
Live feed
·
INSIDERFilingvia Quantisnow
Cytokinetics Incorporated logo

EVP Research & Development Malik Fady Ibraham was granted 27,306 shares, increasing direct ownership by 20% to 165,935 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CYTK· Cytokinetics Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYTK (Cytokinetics Incorporated) and more on Quantisnow.